StocksB › BABA

Alibaba Group Holding Limited (BABA) — Earnings Call X-Ray

Our AI read all 38 of BABA's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q4 2025 · sign up to see
Previous Call Grade
B
Q3 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
6.3/9
evasion 3.2/9
Guidance RaisedSkeptic ReassuredCritic AmmunitionVolume Step-UpEarly Product, Fast GrowthRaising PricesDemand AcceleratingCapex Increasing

Call-by-call analysis

🔒 Q4 2025 earnings call 2025-05-15 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q4 2025 call grade is ready
The full 37-point AI read of BABA's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

B Q3 2025 earnings call 2025-02-20 move ±14.5%

Management raised guidance against accelerating demand. The delivery was rich in specifics.

Guidance: raisedDemand: acceleratingMargins: stablePricing: raisingCapex: increasing 7 analysts · 9 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 6/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q2 2025 earnings call 2024-11-15 move ±8.6%

Management held guidance steady against accelerating demand. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: mixedPricing: stableCapex: increasing 8 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 4/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q1 2025 earnings call 2024-08-15 move ±10.6%

Management held guidance steady against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: contractingBacklog: growingPricing: under pressureCapex: increasing 10 analysts · 12 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 4/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q4 2024 earnings call 2024-05-14 move ±10.2%

Management held guidance steady against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: contractingPricing: under pressureCapex: increasing 9 analysts · 9 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthHidden segment
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q3 2024 earnings call 2024-02-07 move ±12.3%

Management gave no formal guidance against steady demand. The delivery was rich in specifics.

Demand: stablePricing: under pressureCapex: increasing 9 analysts · 15 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Early product, fast growth⚑ Reads rehearsedHidden segment
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 6/9
Uncertainty 4/9
Promotion 5/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q2 2024 earnings call 2023-11-16 move ±10.2%

Management gave no formal guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.

Demand: mixedMargins: expandingPricing: under pressureCapex: increasing 5 analysts · 6 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q1 2024 earnings call 2023-08-10 move ±11.7%

Management gave no formal guidance against mixed demand signals and expanding margins. The delivery was rich in specifics.

Demand: mixedMargins: expandingPricing: stableCapex: decreasing 7 analysts · 9 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Early product, fast growth
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
YES Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2023 2023-05-18 F nonemixedexpanding 5/9 6/9
Q3 2023 2023-02-23 C+ nonemixedexpanding 6/9 3/9
Q2 2023 2022-11-17 D noneslowingexpanding 6/9 4/9
Q1 2023 2022-10-12 D nonemixedcontracting 6/9 3/9
Q4 2022 2022-05-26 D withdrawnslowingcontracting 7/9 3/9
Q3 2022 2022-02-24 F noneslowingcontracting 6/9 5/9
Q2 2022 2021-11-21 F loweredslowingcontracting 6/9 5/9
Q1 2022 2021-08-03 F maintainedstablecontracting 6/9 4/9
Q4 2021 2021-05-13 C raisedacceleratingcontracting 7/9 3/9
Q3 2021 2021-02-02 F nonestablecontracting 6/9 4/9
Q2 2021 2020-11-05 C+ maintainedacceleratingstable 6/9 4/9
Q1 2021 2020-08-20 B maintainedacceleratingexpanding 7/9 2/9
Q4 2020 2020-05-22 B+ raisedmixedstable 7/9 2/9
Q4 2019 2020-02-13 D loweredmixedcontracting 7/9 3/9
Q3 2019 2019-11-01 C+ maintainedacceleratingexpanding 6/9 3/9
Q2 2019 2019-08-16 B maintainedacceleratingexpanding 6/9 3/9
Q4 2019 2019-05-15 C+ maintainedacceleratingcontracting 6/9 3/9
Q3 2019 2019-01-30 C maintainedstablecontracting 6/9 4/9
Q2 2019 2018-11-02 D loweredmixedcontracting 7/9 3/9
Q1 2019 2018-08-23 C+ noneacceleratingcontracting 7/9 3/9
Q4 2018 2018-05-04 B raisedacceleratingcontracting 6/9 4/9
Q3 2018 2018-02-02 B raisedacceleratingcontracting 6/9 3/9
Q2 2018 2017-11-02 B+ raisedacceleratingcontracting 6/9 3/9
Q1 2018 2017-08-17 B+ maintainedacceleratingexpanding 7/9 1/9
Q4 2017 2017-05-18 C+ noneacceleratingexpanding 6/9 3/9
Q3 2017 2017-01-24 B+ raisedacceleratingcontracting 6/9 2/9
Q2 2017 2016-11-02 C+ maintainedacceleratingstable 6/9 2/9
Q1 2017 2016-08-11 A maintainedacceleratingexpanding 7/9 1/9
Q4 2016 2016-05-05 C+ noneacceleratingstable 6/9 3/9
Q3 2016 2016-01-28 C nonemixedcontracting 5/9 3/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of BABA's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

F Q4 2023 earnings call 2023-05-18

316 more research questions answered NO

B Q3 2018 earnings call 2018-02-02

1 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

A · Agilent Technologies, InAAFRF · Airtel Africa PlcAAIC · Arlington Asset InvestmeAAUKF · Anglo American plcAB · AllianceBernstein HoldinABC · AmerisourceBergen Corpor

BAA   All “B” companies    BABWF

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.